09Jun 2021
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors

Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors

Multiple pathophysiological disturbances contribute to the onset and progression of diabetic kidney disease (DKD). This Review describes these pathogenic processes and discusses the ability of sodium–glucose co-transporter 2 (SGLT2) inhibitors to correct or improve many of these processes, which are likely to underlie the ability of these agents to slow progression of established diabetic kidney disease.

  • #nephrology

Like

Save

Share